Neurobiology of Propofol Addiction and Supportive Evidence: What Is the New Development?
Propofol is a short-acting intravenous anesthetic agent suitable for induction and maintenance of general anesthesia as well as for procedural and intensive care unit sedation. As such it has become an unparalleled anesthetic agent of choice in many institutional and office practices. However, in ad...
Main Authors: | Ming Xiong, Nimisha Shiwalkar, Kavya Reddy, Peter Shin, Alex Bekker |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-02-01
|
Series: | Brain Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/2076-3425/8/2/36 |
Similar Items
-
Propofol Inhibits Proliferation and Augments the Anti-Tumor Effect of Doxorubicin and Paclitaxel Partly Through Promoting Ferroptosis in Triple-Negative Breast Cancer Cells
by: Chen Sun, et al.
Published: (2022-03-01) -
Brain Mechanisms during Course of Anesthesia: What We Know from EEG Changes during Induction and Recovery
by: Satoshi Hagihira, et al.
Published: (2017-05-01) -
Efficacy and Safety of Fospropofol Disodium for Injection in General Anesthesia Induction for Adult Patients: A Phase 3 Trial
by: Chao-Meng Wu, et al.
Published: (2021-09-01) -
Taurine activates GABAergic networks in the neocortex of immature mice
by: Bogdan Aurel Sava, et al.
Published: (2014-02-01) -
Novel propofol derivatives and implications for anesthesia practice
by: Aiden Y Feng, et al.
Published: (2017-01-01)